MedTrace Logo

Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)

NCT04599660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2024-02-01

No results posted yet for this study

Summary

This is a multi-institutional retrospective study in order to identify the most relevant and advisable features of follow-up, and to explore its impact on principal clinical outcomes. Moreover, a dedicated effort will be pursued to identify the peculiar characteristics (if any) of patients that experienced recurrence of the disease.

The study will collect data about patients affected by primary GIST at very-low and low risk of recurrence/progression, referred to participating Institutions between January 2000 and February 2020

Conditions

Interventions

OTHER

Treatment of Low Risk GISTs according clinical practice (includes drugs, surgery or any other received treatments)

This observational study collects all the treatments received by the patients according clinical practices or experimental trials and therefore includes drug/biological/surgical and any other applicable treatments

Sponsors & Collaborators

  • Italian Sarcoma Group

    lead NETWORK

Principal Investigators

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-25
Primary Completion
2021-12-30
Completion
2023-12-20

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04599660 on ClinicalTrials.gov